Renal involvement follows cardiac enlargement in essential hypertension by Kobrin, Issac et al.
Renal Involvement Follows Cardiac
Enlargement in Essential Hypertension
Isaac Kobrin, MD; Edward D. Frohlich, MD; Hector O. Ventura, MD; Franz H. Messerli, MD
\s=b\To assess the relationship between early clinically detect-
able involvement of hypertensive vascular disease in heart
and kidneys, we obtained systemic and renal hemodynamic
and M-mode echocardiographic measurements in 65 patients
with essential hypertension. The results indicate that patients
with and without left ventricular hypertrophy had similar renal
hemodynamic findings. In contrast, patients with altered renal
hemodynamic measurements (ie, reduced renal distribution of
cardiac output and, therefore, absolute renal blood flow with
increased renal vascular resistance) and increased serum uric
acid levels also had increased left ventricular posterior and
septal wall thicknesses and mass index. Moreover, these data
also demonstrated that in patients with altered renal hemo-
dynamics, the lower the renal distribution of cardiac output
and the higher the serum uric acid levels, the greater were the
indexes of cardiac enlargement. These results demonstrated
that the pathophysiological and hemodynamic effects of es-
sential hypertension in the heart precede those in the kidneys.
(Arch Intern Med 1986;146:272-276)
"Doth the heart and the kidneys are target organs of
— hypertension. Left ventricular hypertrophy (LVH)
permits adaptation to the pressure overload; ultimately, if
treatment is not provided, congestive heart failure re¬
sults.13 Renal hemodynamic changes4"9 with a rising serum
uric acid concentration4 are among the most prominent
early signs. Most studies concerned with the effects of
hypertension on target organs have been epidemiologically
oriented or have focused attention on either the heart or
the kidneys; there is a paucity of information relating
the simultaneous effects on both organs. The present
study was designed to assess simultaneously the early
pathophysiological evidence of the effects of hypertension
on these two major target organs in the same patient with
uncomplicated essential hypertension.
PATIENTS AND METHODS
Patients
Sixty-five patients (32 men and 33 women; 34 white and 31 black)
were the subjects of this study. All had uncomplicated established
essential hypertension; their outpatient systolic and diastolic
blood pressures were persistently above 160 and 90 mm Hg,
respectively. None of the patients had elevated serum creatinine or
serum urea nitrogen concentrations, and none had electrocar-
diographic evidence of LVH. All patients either had never received
antihypertensive therapy or had discontinued their medications at
least four weeks previously. In all patients, a complete medical
history and physical examination and appropriate clinical labora¬
tory evaluation failed to reveal a secondary cause for the hyperten¬
sion.10 Each patient provided written informed consent to a pro¬
tocol approved by our institution's review committee.
Hemodynamic Assessment
Systemic and regional hemodynamic measurements were deter¬
mined by methods previously reported in detail.10 In brief, using
the modified Seldinger procedure, the brachial artery and median
antecubital vein were cannulated with polyethylene tubing. Intra-
arterial and venous pressures were monitored continuously. Su¬pine cardiac output was determined in triplicate, using indo-
cyanine green dye (5 mg), after an overnight fast. The rate of renal
plasma flow was determined from the single injection clearance of
p-aminohippurate sodium tagged with iodine 131.10 Renal vascular
resistance was calculated by dividing the mean arterial pressure by
the renal blood flow. Plasma volume was determined from the
decline in plasma radioactivity 15 and 30 minutes after injection of
iodinated 1125 serum albumin.10
Echocardiography
M-mode echocardiograms were recorded in all patients. The
techniques for visualization of the left ventricle were described
previously.11,12 Measurements were made of posterior and septal
wall thicknesses and systolic and diastolic dimensions.13 From
these data, the left ventricular mass index was derived.14 Cardiac
dimensions were regarded as abnormal when posterior or septal
wall thicknesses were 1.2 cm or more or when left ventricular mass
index was greater than 135 g/sq m.13
Group Criteria
To assess early physiological evidence of cardiac and renal
involvement and to relate cardiac with renal function, we catego¬
rized patients according to various criteria.
Cardiac Enlargement.—The entire study group was subdi¬
vided into those individuals with and without LVH, as defined by
the echocardiographic criteria described above.
Reduced Renal Distribution of Cardiac Output.—The normal
ratio of renal blood flow to cardiac output is approximately 20%.15
Therefore, patients with ratios less than 16% were grouped as
having reduced renal distribution of cardiac output; levels of 16% or
more were considered to be normal. No patient demonstrated
clinical evidence of impaired renal excretory function; all had
serum creatinine levels less than 1.7 mg/dL.
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Serum Uric Acid Concentration.—Men and women were ana¬
lyzed separately because of normal differences in serum uric acid
levels with respect to sex. Thus, the entire study group was
subdivided according to whether the serum uric acid concentration
was greater or less than 7.5 mg/dL in men or 5.5 mg/dL in women.
Statistics
Statistical comparisons were made using Student's unpaired
t test, linear regression analysis, and
 2 analysis.16 A probability of
less than 5% was considered to be statistically significant. The
unpaired t test was used when variables of two different subgroups
were compared. Linear regression analysis was applied to the
variables in the entire patient population as well as in each
subgroup, and
 2 analysis was used to assess the difference in
prevalence of LVH between subgroups.
RESULTS
Cardiac Enlargement
No differences were found between patients with and
without LVH (using each cardiac mensuration criterion)
with respect to age, race, body surface area, or systemic
and renal hemodynamic findings. The same number of
patients in each subgroup had a family history of hyperten¬
sion, and the average duration of the disease was similar.
When the data were analyzed for possible differences
between the groups with and without LVH with respect to
each of the criteria for LVH (septal wall thickness, posterior
wall thickness, left ventricular mass index), the results
were confirmed. Thus, only the data obtained from the
groups that were divided according to the posterior wall
thickness are presented in Table 1. Serum uric acid concen¬
trations were slightly higher in the men with LVH, but this
difference was not significant for the entire group (Table 1).
Renal Distribution of Cardiac Output
When the patients were classified according to whether
or not they had reduced renal distribution of cardiac output
to the kidney, no differences were found with respect to age,
sex, race, body weight, body surface area, or systemic
hemodynamic findings (Table 2). Moreover, no differences
were found with respect to smoking habits, history of
alcohol consumption, severity of hypertensive retinopathy,
electrocardiographic findings, or serum lipid, creatinine,
and urea nitrogen concentrations. However, more patients
with reduced renal distribution of cardiac output had a
family history of hypertension (30 vs 20 patients [ 2 = 7.38,
P<.01]) and duration of hypertension greater than five
years (22 vs 13 patients [ 2 = 4.43, P<.05]).
By design, renal blood flow rates were lower and renal
vascular resistance was higher in the patients with re¬
duced renal distribution of cardiac output, even though
the arterial pressures in the two groups were similar(160 ± 3/91 ± 2 vs 158 ± 3/93 ± 2 mm Hg). The serum uric acid
concentration, which reflects renal vascular involvement in
hypertension,4 was significantly higher in the patients with
reduced fractions of renal blood flow. And most noteworthy
were the findings that all three cardiac measurements (ie,
posterior and septal wall thicknesses and left ventricular
mass index) were significantly larger in patients with
reduced renal blood flow (Table 2). Furthermore, the preva¬
lence of LVH (ie, with respect to each of the three criteria)
was significantly greater in patients with reduced renal
blood flow (Table 3). Significant correlations were found
between the percent distribution of cardiac output to the
kidneys and the posterior wall thickness (r= .423, P<.05),
septal wall thickness (r= .448, P<.05), and left ventricular
mass index (r=.415, P<.05) in the patients with renal
hemodynamic impairment and cardiac enlargement.
The plasma volumes in patients with reduced renal
distribution of cardiac output were significantly greater
than in patients with normal renal distribution of cardiac
output. These results were further substantiated when the
men were assessed separately; their mean plasma volumes
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were 19.1±0.5 and 16.9±0.5 mL/cm in patients with re¬
duced and normal cardiac output distribution to the kid¬
neys, respectively (P<.02). Because of greater variation of
plasma volume (eg, during the menstrual cycle),1718 these
data did not achieve statistical significance in women(16.9 ±0.5 and 15.4 + 0.6 mL/cm, respectively).
When the men and women were categorized according to
whether their serum uric acid concentrations were greater
or less than 7.5 or 5.5 mg/dL, respectively, significant
differences were revealed (Table 4). Thus, patients of both
sexes with higher uric acid concentrations had significantly
greater cardiac enlargement. In addition, the women with
higher uric acid levels also had significantly lower renal
blood flow rates and higher renal vascular resistances(Table 4). This difference was not found in the men, al¬
though the data reflected lower renal blood flows in those
patients with higher uric acid levels. Moreover, in both
sexes, significant correlations were obtained between the
serum uric acid concentration and cardiac dimensions:
posterior wall thickness (r= .415, P<.05), septal wall thick¬
ness (r=.420, P<.05), and left ventricular mass index(r=.438, P<.05).
 Impairment was defined as distribution of less than 16%. PW indicates
posterior wall; SW, septal wall; and LVMI, left ventricular mass index.
COMMENT
The heart and the kidneys are two of the three major
target organs affected by hypertension. With early organ
involvement, patients usually are asymptomatic, and there
is no clinical evidence of cardiac or renal functional impair¬
ment. However, during this asymptomatic phase, struc¬
tural and physiological changes develop in these organs,
and, therefore, it is important to identify the early clinical
findings that can point toward early detection of target
organ involvement.3·4,12
As hypertensive vascular disease progresses, total pe¬
ripheral resistance increases, and with it left ventricular
afterload.1"3 The left ventricle adapts to this increasing
afterload by concentric hypertrophy, the earliest clinical
evidence of which is left atrial enlargement (disclosed by
electrocardiography) and the atrial diastolic gallop rhythm(fourth heart sound).13"'12·19'20 The hemodynamic changes in
the kidney include increased renal vascular resistance,
decreased renal blood flow, and, ultimately, development of
nephrosclerosis and renal failure." An elevated serum uric
acid concentration is found in uncomplicated essential hy¬
pertension and correlates with the two former hemody¬
namic indexes.4
Although these pathophysiological developments in the
heart and kidneys are well established, there is a paucity of
information about their coexistence and about whether one
organ involvement may precede development of the other.
The results of the present study indicate that these patients
with uncomplicated essential hypertension, with or without
echocardiographically demonstrable LVH, have similar re¬
nal hemodynamic findings. However, once renal hemo¬
dynamic function is altered (ie, once renal blood flow is
slightly reduced and renal vascular resistance is increased),
the left ventricular mass and wall thickness are already de-
monstrably greater than in patients with the same arterial
pressure but with normal renal hemodynamic findings.
Some of the patients with uncomplicated essential hyper¬
tension reported herein had been treated in the past with
antihypertensive agents that may have reduced their car¬
diac mass. This possibility only serves to reinforce the
foregoing observation, since the renal hemodynamic find¬
ings were similar in the groups with and without cardiac
enlargement and the degree of cardiac enlargement would
only have been greater without antihypertensive therapy.
Reduced renal blood flow in hypertensive patients is
among the earliest renal hemodynamic changes.4"9 The
absolute rate of renal blood flow associated with these
changes depends on a variety of factors, including the age,
race, and sex of the patient as well as renal mass and
systemic hemodynamics. As a result, serial measurements
in the same individual are necessary in order to assess
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changes in renal blood flow as disease progresses. However,
this is neither feasible nor ethical. For this reason, we chose
to classify our patients on the basis of renal distribution of
cardiac output.
As might be expected, those patients with reduced renal
distribution of cardiac output had significantly lesser renal
blood flow and higher renal vascular resistances. Further¬
more, they also had significantly larger and thicker left
ventricular chambers than those with no renal hemody¬
namic impairment. Thus, even though both groups of pa¬
tients with uncomplicated essential hypertension had
similar levels of arterial pressure and total peripheral
resistance, their target organ involvement was different.
One explanation might be differences with respect to familyhistory and duration of hypertension. Indeed, this seemed
to hold true; more patients in the subgroup with lower renal
blood flow rates and LVH had family histories and relatively
long personal histories of hypertension, lending further
credence to the notion that the duration ofhypertension and
genetic predisposition are important factors.
Reduced distribution of cardiac output to the kidneys was
associated with greater circulating plasma volumes and
higher serum uric acid concentrations. Previous studies
from our laboratory have shown that increased arterial
pressure was associated with contracted plasma volume in
men with essential hypertension and normal renal hemo¬
dynamic findings.18·21,22 In contrast, patients with paren¬
chymal disease and hypertension, primary aldosteronism,
or with low-renin essential hypertension may have volume-
dependent hypertension.23·24 The present study suggests
that patients with uncomplicated essential hypertension
but with reduced renal distribution of cardiac output may
have a more volume-dependent form of hypertension.
Hyperuricemia has long been known to be a frequent
finding in untreated patients with uncomplicated essential
hypertension unassociated with a personal or family history
of gout.25-29 As indicated above, we recently reported that
serum uric acid concentration increases in patients with
uncomplicated essential hypertension and is associated
with early renal hemodynamic involvement from hyperten¬
sive vascular disease.4 Thus, the higher the serum uric acid
levels in these patients with essential hypertension and
normal renal excretory function (and normal-size hearts),
the lower the renal blood flow rate and the renal vascular
resistance. These findings relating serum uric acid levels to
intrarenal hemodynamic alterations supported earlier ob¬
servations of rises in serum uric acid concentration in
normotensive subjects during infusions of pressor doses of
norepinephrine or angiotensin II.30 In these normal volun¬
teer subjects, as arterial pressure and the uric acid level
rose, glomerular filtration rates remained unchanged as
renal plasma flow and urate excretion declined. Then, with
cessation of these pressor infusions, as arterial pressure
and renal plasma flow returned to normal levels, so did
urate excretion and the serum uric acid concentration. The
data from these two studies4,30 strongly suggest that the
serum uric acid level reflects not only alterations in purine
metabolism or in renal parenchymal functions mediating tu¬
bular urate excretion but also intrarenal hemodynamic
function.
The present data further strengthen that concept: re¬
duced renal fractions of cardiac output were associated with
higher concentrations of uric acid. Moreover, when our
patients were classified according to their uric acid levels,
regardless of renal hemodynamic values, those with higher
serum uric acid concentrations had larger left ventricles.
These findings add further support to the concept that the
first evidence of renal involvement is an increasing serum
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uric acid concentration and that the renal distribution of
cardiac output falls as renal hemodynamic involvement
progresses.
We therefore conclude that renal involvement in essential
hypertension is usually preceded by cardiac enlargement
and that an increasing serum uric acid level may be an early
sign of renal involvement in patients with essential hyper¬
tension, which is later followed by a reduction in the renal
distribution of cardiac output.
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CORRECTION
Incorrect Data.\p=m-\Inan article titled "Time and Financial Analysis of an
Academic General Internal Medicine Unit," published in the November 1985
Archives (1985;145:2093-2097), errors appeared in the key to Fig 2. "Inpatient:
Consults (Direct Care)" should have been indicated by the top dotted bar, and
"Inpatient: Medical Service (Direct Care)" should have been indicated by the
solid dark bar.
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